Development of ertapenem resistance in a patient with mediastinitis caused by Klebsiella pneumoniae producing an extended-spectrum β-lactamase
Authors:
- 1 January 2010
- journal article
- case report
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 59 (1) , 115-119
Abstract
The aim was to study the clinical and microbiological features associated with a carbapenem-resistant Klebsiella pneumoniae isolate that had been selected in vivo by an ertapenem-containing regimen in a patient with mediastinitis despite high blood and mediastinal levels of ertapenem. Carbapenem resistance was characterized by conjugation, PCR, DNA sequencing and analysis of outer-membrane proteins. The isolates susceptible and resistant to the carbapenems were compared by ribotyping and PFGE. Resistance to all available β-lactams was most probably due to combined production of extended-spectrum β-lactamase (ESBL) CTX-M-15 and loss of OmpK36 porin. The results of ribotyping and PFGE suggest that the carbapenem-resistant strain was a derivative of the original mediastinal isolate rather than a superinfecting isolate. This observation stresses the risk of selection of pan-penem resistant strains of enterobacteria when ertapenem is used for the treatment of severe infections due to ESBL-producing enterobacteria.Keywords
This publication has 17 references indexed in Scilit:
- Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniaeJournal of Medical Microbiology, 2009
- Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated β-lactamase production and OmpK36 porin deficiencyJournal of Medical Microbiology, 2009
- Ertapenem Resistance among Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae IsolatesJournal of Clinical Microbiology, 2009
- Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UKJournal of Antimicrobial Chemotherapy, 2009
- In Vivo Development of Ertapenem Resistance in a Patient with Pneumonia Caused by Klebsiella pneumoniae with an Extended-Spectrum -LactamaseClinical Infectious Diseases, 2006
- Acquisition of Resistant Bowel Flora during a Double-Blind Randomized Clinical Trial of Ertapenem versus Piperacillin-Tazobactam Therapy for Intraabdominal InfectionsAntimicrobial Agents and Chemotherapy, 2005
- High Levels of Antimicrobial Coresistance among Extended-Spectrum-β-Lactamase-Producing EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 2005
- Ertapenem, the first of a new group of carbapenemsJournal of Antimicrobial Chemotherapy, 2003
- Ertapenem Versus Piperacillin/Tazobactam in the Treatment of Complicated Intraabdominal InfectionsAnnals of Surgery, 2003
- A complementation analysis of the restriction and modification of DNA in Escherichia coliJournal of Molecular Biology, 1969